The Washington Post   |  October 7, 2021

“There’s this monopolistic grip of a few countries that really controls the narrative, and the availability and the access of lifesaving medical resources — and there’s enormous global resentment about that,” said Lawrence O. Gostin, a global health law expert at Georgetown Law. “Donations always seem to come too late, and be insufficient. … Opening up manufacturing plants in other countries is certainly a step forward, but it doesn’t really change the dynamic.”

Read more here.